Corrigendum to: Current practice and surgical outcomes of neoadjuvant chemotherapy for early breast cancer: UK NeST study.
作者信息
Fatayer Hiba, O'Connell Rachel L, Bannon Finian, Coles Charlotte E, Copson Ellen, Cutress Ramsey I, Dave Rajiv V, Gardiner Matthew D, Grayson Margaret, Holcombe Christopher, Irshad Sheeba, Irwin Gareth W, O'Brien Ciara, Palmieri Carlo, Shaaban Abeer M, Sharma Nisha, Singh Jagdeep K, Whitehead Ian, Potter Shelley, McIntosh Stuart A
出版信息
Br J Surg. 2022 Dec 13;110(1):124. doi: 10.1093/bjs/znac282.
Abstract
摘要
相似文献
1
Corrigendum to: Current practice and surgical outcomes of neoadjuvant chemotherapy for early breast cancer: UK NeST study.《早期乳腺癌新辅助化疗的当前实践与手术结果：英国NeST研究》勘误
Br J Surg. 2022 Dec 13;110(1):124. doi: 10.1093/bjs/znac282.
2
Current practice and surgical outcomes of neoadjuvant chemotherapy for early breast cancer: UK NeST study.早期乳腺癌新辅助化疗的当前实践及手术结果：英国NeST研究
Br J Surg. 2022 Aug 16;109(9):800-803. doi: 10.1093/bjs/znac131.
3
Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer.蒽环类药物与紫杉烷类药物在早期乳腺癌新辅助和辅助治疗中的序贯应用
Cochrane Database Syst Rev. 2019 Feb 18;2(2):CD012873. doi: 10.1002/14651858.CD012873.pub2.
4
5
Neoadjuvant or adjuvant chemotherapy in early breast cancer?早期乳腺癌的新辅助化疗还是辅助化疗？
Expert Opin Pharmacother. 2020 Jun;21(9):1071-1082. doi: 10.1080/14656566.2020.1746273. Epub 2020 Apr 1.
6
Pathologic evaluation of specimens after neoadjuvant chemotherapy in breast cancer: Current recommendations and challenges.乳腺癌新辅助化疗后标本的病理评估：当前建议与挑战
Pathol Res Pract. 2022 Feb;230:153753. doi: 10.1016/j.prp.2021.153753. Epub 2021 Dec 29.
7
Accuracy of MRI for estimating residual tumor size after neoadjuvant chemotherapy in locally advanced breast cancer: relation to response patterns on MRI.MRI评估局部晚期乳腺癌新辅助化疗后残余肿瘤大小的准确性：与MRI反应模式的关系
Acta Oncol. 2007;46(7):996-1003. doi: 10.1080/02841860701373587.
8
A Review of the Impact of Neoadjuvant Chemotherapy on Breast Surgery Practice and Outcomes.新辅助化疗对乳腺癌手术实践和结果影响的综述。
Clin Breast Cancer. 2019 Oct;19(5):377-382. doi: 10.1016/j.clbc.2019.04.011. Epub 2019 May 2.
9
Comparison of overall survival after neoadjuvant and adjuvant chemotherapy in patients with early breast cancer with immediate breast reconstruction after mastectomy: A retrospective, matched case-control study.早期乳腺癌患者乳房切除术后即刻乳房重建行新辅助化疗与辅助化疗后总生存情况比较：一项回顾性配对病例对照研究
Oncol Lett. 2022 Oct 21;24(6):437. doi: 10.3892/ol.2022.13557. eCollection 2022 Dec.
10
Neoadjuvant Chemotherapy for Breast Cancer, Is Practice Changing? A Population-Based Review of Current Surgical Trends.乳腺癌新辅助化疗：实践正在改变吗？基于人群的当前手术趋势回顾。
Ann Surg Oncol. 2015 Oct;22(10):3376-82. doi: 10.1245/s10434-015-4714-x. Epub 2015 Jul 23.
引用本文的文献
1
Threonine and tyrosine kinase (TTK) mRNA and protein expression in breast cancer; prognostic significance in the neoadjuvant setting.苏氨酸和酪氨酸激酶（TTK）在乳腺癌中的mRNA和蛋白质表达；新辅助治疗环境中的预后意义。
Histopathology. 2025 May;86(6):916-932. doi: 10.1111/his.15399. Epub 2025 Jan 7.
Zotero 插件